Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Cancer), Usage Pattern (Immunization), Administration (Skin, Musculoskeletal), Distribution Channel (Hospital), Patient Care Setting (Hospital, Home Care) - Forecast to 2021
Inquire Now to get the global numbers on Injectable Drug Delivery Market
MarketsandMarkets forecasts the injectable drug delivery market to grow from USD 362.4 billion in 2016 to USD 624.5 billion by 2021, at a Compound Annual Growth Rate (CAGR) of 11.5% during the forecast period. The major factors responsible for the growth of this market are the increasing use of biologics, increase in the prevalence of chronic diseases, increasing occurrence of needlestick injuries, and the benefits of injections (convenience, ease of use, and reduced pain). These factors have increased the demand for devices such as safety syringes, prefilled syringes, and autoinjectors.
The objective of the report is to define, describe, and forecast the injectable drug delivery market size based on type, formulation packaging, therapeutic application, usage pattern, site of administration, distribution channel, facility of use, and region.
Helped the client to devise go-to-market strategies and identify customers for potential opportunities in a ~USD 10 million market
Client’s Problem Statement
Owen Mumford (a UK-based medical device manufacturing company), was exploring opportunities in the global injectable drug delivery market.
MnM Approach
The client utilized MnM expertise to understand the geographic opportunities that have unmet needs and the highest market potential.
Revenue Impact (RI)
Impact on the client’s decision: By utilizing insights from our study, the client devised go-to-market strategies as well as identified customers for potential opportunities in the ~USD 1 billion market during the next five years. Our analysis is thus expected to offer an incremental impact of greater than USD 10 million during the next one year.
By type, the formulation segment to witness the highest growth during the forecast period (2016–2021).
Based on type, the injectable drug delivery market is further segmented into formulation, and devices. The formulation segment is expected to grow at the highest CAGR during the forecast period. The high growth of this market segment is attributed to the growing prevalence of chronic diseases, patient adherence, and the rising adoption of self-injection, new technologies, and biologics.
By facility of use, the hospitals and clinics segment to dominate during the forecast period
The hospitals and clinics segment are expected to dominate the market. The large share of this segment is attributed to the rising prevalence of chronic diseases, patient compliance, and technological advancements.
North America to account for the largest market size during the forecast period.
North America is expected to hold the largest market size in autoinjector market during the forecast period, followed by the European region. Factors such as the increasing incidence of chronic diseases, growth of biologicd market, and increasing demand of self-injection devices.
Asia is the third-largest market for Needle-free injector market. This market is poised to witness the highest growth due to the increasing prevalence of chronic diseases, rise in disposable income, growing awareness on safety and comfort, and increasing number of partnerships in this market space.
Market Dynamics
Driver: Growth in biologics market
According to the American Journal of Managed Health Care, biologics form the fastest-growing segment in the pharmaceutical market. An article published by PHARMAC stated that between 2007 and 2012, the global spending on all medicines increased by 24%; in the same period, the spending on biologics increased by 367%.
According to an article published by The Economist, in the U.S., more than 900 biologics are under development for the treatment of more than 100 diseases. It is estimated that approximately USD 170 billion is spent on biologics globally, and this figure is expected to grow to approximately USD 220 billion by 2017. A major factor responsible for this trend is the rising demand for vaccines, insulin, human growth hormone, and many modern medicines used to treat cancer and other chronic diseases. As biologics are mainly administered through the injectable route, the significant growth in the biologics market is expected to drive the injectable drug delivery and prefilled syringe market in the coming years.
Biologics currently account for approximately 70% of the top-10 selling drugs in the world (Source: BioPharm International). Considering the significant demand for and potential of biologics, market players are focusing on undertaking strategic developments to leverage the growth opportunities in this market segment.
A key product in the injectable drug delivery market is Humira (AbbVie Inc.), which is used for the treatment of moderate to severe rheumatoid arthritis (RA). Enbrel (Pfizer) is a prescription medicine that can be self-injected and is used for the treatment of long-term inflammatory diseases. Herceptin (Roche) is a subcutaneous injection used for the treatment of cancer.
Restraint: Product recall
In recent years, there have been numerous product recalls in the injectable drug delivery technology market. Recalls can be voluntary or can result after the intervention of regulatory authorities. Usability issues must be identified and addressed during the development process. The presence of visible foreign matter during the testing of retention samples in injectables can cause severe health consequences such as permanent impairment of a body function, damage and/or obstruction of blood vessels, local inflammation, phlebitis, allergic response and/or embolization in the body, and infection. Other reasons due to which injectables face recalls are contamination from inorganic materials such as glass, silicone, and stainless steel, and also due to incomplete filling of vials.
If a product is recalled, the process of retrieving and replacing the defective product may cause a company or a manufacturer to incur huge losses associated with the replacement and fixing of faulty products. These huge losses will affect the revenue and the share of the company in the market, which in turn will impact the overall market.
Opportunity: Contraceptive injectable
Over the years, the use of injectable contraceptives has increased significantly. This increased use of injectable contraceptives can mainly be attributed to their high efficacy. Injectable contraceptives are not required to be taken daily; they can be administered once every month or once every three months and are considered to be one of the safer modes of pregnancy prevention. They prevent pregnancy 99% of the time, when administered correctly. Due to these reasons the demand for contraceptive injectables is expected to drive the market in future.
According to Guttmacher Institute, in 2012, around 1,697,000 women used injectables for contraception in the U.S. Noristerat Injection is a reversible method of prescription birth control, which is common in the U.K. and other parts of Europe.
Many new products are being launched in contraceptive injections. For instance; in September 2015, Pfizer Inc. launched Sayana Press, the first injectable contraceptive in the U.K. for administration by self-injection.
Challenge: Contraceptive injectable Preference for other mode of drug delivery
The injectable mode of drug delivery offers a large surface area for absorption as a result of which it achieves rapid systemic levels of absorption. However, the use of injectables can lead to needlestick injuries and infections, needle phobia, anxiety, and pain. All these factors limit the market for injectables to a certain extent. Among the various routes of drug delivery, the oral route is the most preferred as it is easy to use, convenient, cost-effective, safe, and acceptable.
Inhalation facilitates rapid absorption due to the huge surface area of the respiratory endothelium; bronchodilators and inhaled steroids can be targeted at the lungs with low levels of systemic absorption. The topical route of drug administration is considered better than injections as drugs are applied directly to the skin and it is non-invasive, easy, and there is a high level of patient compliance.
This preference for other routes of drug administration is a major challenge for the injectable drug delivery technology market.
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
Request Sample Scope of the Report
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
|
Report Metric |
Details |
|
Market size available for years |
2014–2021 |
|
Base year considered |
2015 |
|
Forecast period |
2016–2021 |
|
Forecast units |
Billion (USD) |
|
Segments covered |
Type (Devices, and Formulations), packaging formulations (Ampoules, Vials, Cartridges, and bottles), therapeutic application (autoimmune diseases, hormonal disorders, orphan diseases, cancer, other therapeutic application) usage patter (curative care, immunization, and other), site of administration (skin, circulatory/musculoskeletal system, organs, central nervous system), distribution channel (hospital, and retail pharmacy stores), facility of use (hospitals and clinics, home care settings, other facility of use) and region |
|
Geographies covered |
North America, Europe, Asia, and Rest of the World |
|
Companies covered |
Becton, Dickinson and Company (U.S.), Pfizer Inc. (U.S.), Teva Pharmaceuticals Industries Ltd. (Israel), Eli Lilly and Company (U.S.), Baxter International, Inc. (U.S.), Schott AG (Germany), Gerresheimer (Germany), Ypsomed (Switzerland), and B. Braun Melsungen (Germany). |
The research report categorizes the injectable drug delivery market to forecast the revenues and analyze the trends in each of the following sub-segments:
Injectable Drug Delivery Market, by Type
- Devices
- Formulations
Injectable Drug Delivery Market, by Formulation Packaging
- Ampules
- Vials
- Cartridges
- Bottles
Injectable Drug Delivery Market, by Therapeutic Application
- Auto-immune diseases
- Hormonal Disorders
- Orphan Diseases
- Oncology
- Other Therapeutic Applications
Injectable Drug Delivery Market, by Usage Pattern
- Curative Care
- Immunization
- Other Usage Pattern
Injectable Drug Delivery Market, by Site of Administration
- Skin
- Circulatory/Musculoskeletal
- Organs
- Central Nervous System
Injectable Drug Delivery Market, by Distribution Channel
- Hospitals
- Retail Pharmacy Stores
Injectable Drug Delivery Market, by Facility of Use
- Hospitals & Clinics
- Home Care Settings
- Other Facilities of Use
Injectable Drug Delivery Market, by Region
-
North America
- U.S.
- Canada
-
Europe
- Germany
- France
- U.K
- Rest of Europe (RoE)
-
Asia
- China
- India
- Japan
- Rest of Asia (RoA)
- Rest of the World (RoW)
Key Market Players
Prominent players in the injectable drug delivery market are Becton, Dickinson and Company (U.S.), Pfizer Inc. (U.S.), Teva Pharmaceuticals Industries Ltd. (Israel), Eli Lilly and Company (U.S.), Baxter International, Inc. (U.S.), Sandoz (Germany), Terumo (Japan), Schott AG (Germany), Gerresheimer (Germany), Ypsomed (Switzerland), Bespak (U.K.), and B. Braun Melsungen (Germany).
Becton, Dickinson and Company (U.S.) led the injectable drug delivery market in 2015. The company offers an exclusive product portfolio comprising a variety of pen injectors, autoinjectors, autodisable injection systems, and conventional injections and syringes. It focuses on both organic as well as inorganic growth strategies to maintain its leading position in the market. For instance, in March 2015, BD acquired CareFusion Corp. (U.S.) to expand its offerings and provide better medication management and patient safety solutions. In the same year, BD acquired CRISI Medical Systems (U.S.), a company that operates in medical technology, to increase the efficiency of drug delivery through IV injectables. BD has its presence in 50 countries across the globe, which enables it to maintain its position in global market.
Recent Developments
- In 2016, Gerresheimer extended its partnership with Taisei Medical Co. Ltd. (Japan) with an aim to market its ClearJect syringes and provide technical support to its customers. Furthermore, in collaboration with Taisei Medical, the company intends to expand its COP syringe portfolio by manufacturing a new Gx RTF ClearJect brand by combining ClearJect with its glass RTF (ready-to-fill) concept. This partnership is expected to help the company expand its product portfolio and customer base in the syringes market.
- In 2015, Eli Lilly and Company and Sanford-Burnham Medical Research Institute (U.S.) entered into a collaboration for the development of immunological therapies focusing on lupus, Sjögren's syndrome, inflammatory bowel disease, and other autoimmune disorders. This collaboration will combine the expertise of both organizations to develop novel treatments for these diseases.
- In 2014, Terumo Corporation collaborated with Ypsomed Group (a Switzerland-based injection systems manufacturer). Through this collaboration, the company integrated its prefillable polymer syringe, namely, PLAJEX with YpsoMate (an autoinjector system from Ypsomed). This helped the company strengthen its product offerings in the syringes market.
Critical questions the report answers:
- Where will all these developments take the industry in the long term?
- What are the upcoming trends for the autoinjector market, and Needle-Free Injectors market market?
- Which segment provides the most opportunity for growth?
- Who are the leading vendors operating in this market?
- What are the opportunities for new market entrants?
Available customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Table of Contents
1 Introduction (Page No. - 36)
1.1 Objectives of The Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
Figure 1 Injectable Drug Delivery Market
1.3.2 Years Considered for The Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology (Page No. - 39)
Figure 2 Research Design
2.1 Market Size Estimation
Figure 3 Market Size Estimation: Bottom-Up Approach
Figure 4 Market Size Estimation: Top-Down Approach
Figure 5 Breakdown of Primary Interviews: By Company, Designation and Region
2.2 Market Breakdown and Data Triangulation
Figure 6 Data Triangulation Methodology
2.3 Key Data From Secondary Sources
2.4 Key Data From Primary Sources
2.5 Assumptions for The Study
3 Executive Summary (Page No. - 46)
Figure 7 Injectable Drug Delivery Market Snapshot,By formulation 2016 Vs. 2021 (USD Billion)
Figure 8 Injectable Drug Delivery Market, By Facility of Use2016 Vs. 2021 (USD Billion)
Figure 9 Injectable Drug Delivery Market, By Therapeutic Application, 2016 Vs 2021 (USD Billion)
Figure 10 Injectable Drug Delivery Market, By Region (2016-2021)
4 Premium Insights (Page No. - 49)
4.1 Injectable Drug Delivery: Market Overview
Figure 11 Increasing Use of Biologic Drugs and Rising Prevalence of Chronic Diseases to Drive Market Growth
4.2 Injectable Drug Delivery Market, By Facility of Use
Figure 12 Hospitals and Clinics To Dominate The Market In 2016
4.3 Geographic analysis: Injectable Drug Delivery Market, By Site of Administration
Figure 13 Skin Segment To Command The Largest Market Share In 2016
4.4 Injectable Drug Delivery Market, By formulation Packaging
Figure 14 Ampules to Dominate The Injectable Drug Delivery Market, In 2016
4.5 Geographical Snapshot: Injectable Drug Delivery Market
Figure 15 China to Register Highest Growth Rate During The forecast Period
5 Market Overview (Page No. - 52)
5.1 Introduction
5.2 Market Dynamics
Figure 16 Injectable Drug Delivery Market: Drivers, Restraints, Opportunities, and Challenges
5.2.1 Drivers
5.2.1.1 Rising Prevalence of Chronic Diseases
5.2.1.2 Increase In Demand for Self-Injection Devices
5.2.1.3 Growth In The Biologics Market
5.2.1.4 Technological Advancements and New Product Launches
5.2.2 Restraints
5.2.2.1 Infections Associated With Needlestick Injuries
5.2.2.2 Product Recalls
Table 1 Product Recalls (2013–2015)
5.2.3 Opportunities
5.2.3.1 Increase In Demand for Biosimilar and Generic Injectables
5.2.3.1.1 Biosimilars
5.2.3.1.2 Generic Injectables
Table 2 Injectable Drugs Going off-Patent In The U.S.
5.2.3.2 Contraceptive Injectables
5.2.4 Challenge
5.2.4.1 Preference for Other Modes of Drug Delivery
6 Regulatory Scenario (Page No. - 61)
6.1 Introduction
Table 3 List of Regulatory Authorities In Major Countries
6.2 Fda and Ce Approvals
Table 4 List of Fda Approved In The Market (2015-2016)
6.3 The European Medicines Agency (Ema)
6.4 Clinical Trials
Table 5 Injectable Drugs In Phase Iii Clinical Trials
Table 6 Product Recalls (2015-2016)
7 Injectable Drug Delivery Market, By Type (Page No. - 63)
7.1 Introduction
Table 7 Injectable Drug Delivery Market Size, By Type,2014–2021 (USD Billion)
7.2 Devices
Table 8 Injectable Drug Delivery Devices Market Size, By Type, 2014–2021 (USD Billion)
Table 9 Injectable Drug Delivery Devices Market Size, By Region, 2014–2021 (USD Billion)
7.2.1 Conventional Injection Devices
Table 10 Conventional Injection Devices Market Size, By Region, 2014–2021 (USD Billion)
7.2.1.1 By Material
Table 11 Conventional Injection Devices Market Size, By Material, 2014–2021 (USD Billion)
7.2.1.1.1 Glass
Table 12 Conventional Glass Injection Devices Market Size,By Region, 2014–2021 (USD Billion)
7.2.1.1.2 Plastic
Table 13 Conventional Plastic Injection Devices Market Size,By Region, 2014–2021 (USD Billion)
7.2.1.2 By Product
Table 14 Conventional Injection Devices Market Size, By Product, 2014–2021 (USD Billion)
7.2.1.2.1 Fillable Syringes
Table 15 Conventional Fillable Injection Devices Market Size,By Region, 2014–2021 (USD Billion)
7.2.1.2.2 Prefilled Syringes
Table 16 Conventional Prefilled Injection Devices Market Size,By Region, 2014–2021 (USD Billion)
7.2.1.3 By Usability
Table 17 Conventional Injection Devices Market Size, By Usability, 2014–2021 (USD Billion)
7.2.1.3.1 Reusable Injection Devices
Table 18 Conventional Reusable Injection Devices Market Size,By Region, 2014–2021 (USD Billion)
7.2.1.3.2 Disposable Injection Devices
Table 19 Conventional Disposable Injection Devices Market Size,By Region, 2014–2021 (USD Billion)
7.2.2 Self-Injection Devices
Table 20 Self-Injection Devices Market Size, By Type,2014–2021 (USD Billion)
Table 21 Self-Injection Devices Market Size, By Region,2014–2021 (USD Billion)
7.2.2.1 Needle-Free Injectors
Table 22 Needle-Free Injectors Market Size, By Region,2014–2021 (USD Billion)
7.2.2.1.1 By Product
Table 23 Needle-Free Injectors Market Size, By Product,2014–2021 (USD Billion)
7.2.2.1.1.1 Fillable Needle-Free Injectors
Table 24 Fillable Needle-Free Injectors Market Size, By Region, 2014–2021 (USD Billion)
7.2.2.1.1.2 Prefilled Needle-Free Injectors
Table 25 Prefilled Needle-Free Injectors Market Size, By Region, 2014–2021 (USD Billion)
7.2.2.1.2 By Technology
Table 26 Needle-Free Injectors Market Size, By Technology,2014–2021 (USD Billion)
7.2.2.1.2.1 Jet-Based Needle-Free Injectors
Table 27 List of Some of The Needle-Free Jet Injectors Available In The Market
Table 28 Jet-Based Needle-Free Injectors Market Size, By Region, 2014–2021 (USD Billion)
7.2.2.1.2.2 Spring-Based Needle-Free Injectors
Table 29 List of Some of The Needle-Free Spring-Based Injectors Available In The Market
Table 30 Spring-Based Needle-Free Injectors Market Size, By Region, 2014–2021 (USD Billion)
7.2.2.1.2.3 Laser-Powered Needle-Free Injectors
Table 31 Laser-Powered Needle-Free Injectors Market Size,By Region, 2014–2021 (USD Million)
7.2.2.1.2.4 Vibration-Based Needle-Free Injectors
Table 32 Vibration-Based Needle-Free Injectors Market Size,By Region, 2014–2021 (USD Million)
7.2.2.1.3 By Usability
Table 33 Needle-Free Injectors Market Size, By Usability,2014–2021 (USD Billion)
7.2.2.1.3.1 Reusable Needle-Free Injectors
Table 34 Reusable Needle-Free Injectors Market Size, By Region, 2014–2021 (USD Billion)
7.2.2.1.3.2 Disposable Needle-Free Injectors
Table 35 Disposable Needle-Free Injectors Market Size, By Region, 2014–2021 (USD Billion)
7.2.2.2 Autoinjectors
Table 36 Autoinjectors Market Size, By Region,2014–2021 (USD Billion)
7.2.2.2.1 By Product
Table 37 Autoinjectors Market Size, By Product,2014–2021 (USD Billion)
7.2.2.2.1.1 Fillable Autoinjectors
Table 38 Fillable Autoinjectors Market Size, By Region,2014–2021 (USD Billion)
7.2.2.2.1.2 Prefilled Autoinjectors
Table 39 Prefilled Autoinjectors Market Size, By Region,2014–2021 (USD Billion)
7.2.2.2.2 By Technology
Table 40 Autoinjectors Market Size, By Technology,2014–2021 (USD Billion)
7.2.2.2.2.1 Automated Autoinjectors
Table 41 Automated Autoinjectors Market Size, By Region,2014–2021 (USD Billion)
7.2.2.2.2.2 Manual Autoinjectors
Table 42 Manual Autoinjectors Market Size, By Region,2014–2021 (USD Billion)
7.2.2.2.3 By Design
Table 43 Autoinjectors Market Size, By Design,2014–2021 (USD Billion)
7.2.2.2.3.1 Standardized Autoinjectors
Table 44 Standardized Autoinjectors Market Size, By Region,2014–2021 (USD Billion)
7.2.2.2.3.2 Customized Autoinjectors
Table 45 Customized Autoinjectors Market Size, By Region,2014–2021 (USD Billion)
7.2.2.2.4 By Usability
Table 46 Autoinjector Market Size, By Usability,2014–2021 (USD Billion)
7.2.2.2.4.1 Reusable Autoinjectors
Table 47 Reusable Autoinjectors Market Size, By Region,2014–2021 (USD Billion)
7.2.2.2.4.2 Disposable Autoinjectors
Table 48 Disposable Autoinjectors Market Size, By Region,2014–2021 (USD Billion)
7.2.2.3 Pen Injectors
Table 49 Pen Injectors Market Size, By Region,2014–2021 (USD Billion)
Table 50 Commercially Available Pen Injectors
7.2.2.3.1 By Product
Table 51 Pen Injectors Market Size, By Product,2014–2021 (USD Billion)
7.2.2.3.1.1 Single-Chambered Pen Injectors
Table 52 Single-Chambered Pen Injectors Market Size, By Region, 2014–2021 (USD Billion)
7.2.2.3.1.2 Dual-Chambered Pen Injectors
Table 53 Commercially Available Dual-Chambered Pen Injectors
Table 54 Dual-Chambered Pen Injectors Market Size, By Region, 2014–2021 (USD Billion)
7.2.2.3.2 By Design
Table 55 Pen Injectors Market Size, By Design,2014–2021 (USD Billion)
7.2.2.3.2.1 Standard Pen Injectors
Table 56 Standard Pen Injectors Market Size, By Region,2014–2021 (USD Billion)
7.2.2.3.2.2 Customized Pen Injectors
Table 57 Customized Pen Injectors Market Size, By Region,2014–2021 (USD Billion)
7.2.2.3.3 By Usability
Table 58 Pen Injectors Market Size, By Usability,2014–2021 (USD Billion)
7.2.2.3.3.1 Reusable Pen Injectors
Table 59 Reusable Pen Injectors Market Size, By Region,2014–2021 (USD Billion)
7.2.2.3.3.2 Disposable Pen Injectors
Table 60 Disposable Pen Injectors Market Size, By Region,2014–2021 (USD Billion)
7.2.2.4 Wearable Injectors
Table 61 Wearable Injectors Market Size, By Region,2014–2021 (USD Billion)
7.2.2.5 Other Devices
Table 62 Other Devices Market Size, By Region,2014–2021 (USD Billion)
7.3 formulations
Table 63 Injectable Drug Delivery formulations Market Size,By Type, 2014–2021 (USD Billion)
Table 64 Injectable Drug Delivery formulations Market Size,By Region, 2014–2021 (USD Billion)
7.3.1 Conventional Drug Delivery formulations
Table 65 Conventional Drug Delivery formulations Market Size,By Type, 2014–2021 (USD Billion)
Table 66 Conventional Drug Delivery formulations Market Size,By Region, 2014–2021 (USD Billion)
7.3.1.1 Solutions
Table 67 Solutions Market Size, By Region, 2014–2021 (USD Billion)
7.3.1.2 Reconstituted/Lyophilized formulations
Table 68 Reconstituted/Lyophilized formulations Market Size,By Region, 2014–2021 (USD Billion)
7.3.1.3 Suspensions
Table 69 Suspensions Market Size, By Region,2014–2021 (USD Billion)
7.3.1.4 Emulsions
Table 70 Emulsions Market Size, By Region, 2014–2021 (USD Billion)
7.3.2 Novel Drug Delivery formulations
Table 71 Novel Drug Delivery formulations Market Size, By Type, 2014–2021 (USD Billion)
Table 72 Novel Drug Delivery formulations Market Size, By Region, 2014–2021 (USD Billion)
7.3.2.1 Colloidal Dispersions
Table 73 Colloidal Dispersions Market Size, By Type,2014–2021 (USD Billion)
Table 74 Colloidal Dispersions Market Size, By Region,2014–2021 (USD Billion)
7.3.2.1.1 Niosomes
Table 75 Niosomes Market Size, By Region, 2014–2021 (USD Billion)
7.3.2.1.2 Liposomes
Table 76 Liposomes Market Size, By Region, 2014–2021 (USD Billion)
7.3.2.1.3 Polymeric/Mixed Micelles
Table 77 Polymeric/Mixed Micelles Market Size, By Region,2014–2021 (USD Billion)
7.3.2.1.4 Nanoparticles
Table 78 Nanoparticles Market Size, By Type, 2014–2021 (USD Billion)
Table 79 Nanoparticles Market Size, By Region,2014–2021 (USD Billion)
7.3.2.1.4.1 Solid-Lipid Nanoparticles
Table 80 Solid-Lipid Nanoparticles Market Size, By Region,2014–2021 (USD Billion)
7.3.2.1.4.2 Nanosuspensions
Table 81 Nanosuspensions Market Size, By Region,2014–2021 (USD Billion)
7.3.2.1.4.3 Nanoemulsions
Table 82 Nanoemulsions Market Size, By Region,2014–2021 (USD Billion)
7.3.2.2 Microparticles
Table 83 Microparticles Market Size, By Type,2014–2021 (USD Billion)
Table 84 Microparticles Market Size, By Region,2014–2021 (USD Billion)
7.3.2.2.1 Microspheres
Table 85 Microspheres Market Size, By Region,2014–2021 (USD Billion)
7.3.2.2.2 Microcapsules
Table 86 Microcapsules Market Size, By Region,2014–2021 (USD Billion)
7.3.3 Long-Acting Injection formulations
Table 87 Long-Acting Injection Formulations Market Size, By Region, 2014–2021 (USD Billion)
8 Injectable Drug Delivery Market, By Formulation Packaging (Page No. - 112)
8.1 Introduction
Table 88 Injectable Drug Delivery Market Size, By Formulation Packaging, 2014–2021 (USD Billion)
Table 89 Injectable Drug Delivery Market Size For Formulation Packaging, By Region, 2014–2021 (USD Billion)
8.2 Ampules
Table 90 Injectable Drug Delivery Market Size For Ampules,By Region, 2014–2021 (USD Billion)
8.3 Vials
Table 91 Injectable Drug Delivery Market Size for Vials, By Region, 2014–2021 (USD Billion)
8.4 Cartridges
Table 92 Injectable Drug Delivery Market Size for Cartridges,By Region, 2014–2021 (USD Billion)
8.5 Bottles
Table 93 Injectable Drug Delivery Market Size for Bottles,By Region, 2014–2021 (USD Billion)
9 Injectable Drug Delivery Market, By Therapeutic Application (Page No. - 116)
9.1 Introduction
Table 94 Injectable Drug Delivery Market Size, By Therapeutic Application, 2014–2021 (USD Billion)
9.2 Autoimmune Diseases
Table 95 Injectable Drug Delivery Market Size for Autoimmune Diseases, By Indication, 2014–2021 (USD Billion)
Table 96 Injectable Drug Delivery Market Size for Autoimmune Diseases, By Region, 2014–2021 (USD Billion)
9.2.1 Rheumatoid Arthritis
Table 97 Injectable Drug Delivery Market Size for Rheumatoid Arthritis, By Region, 2014–2021 (USD Billion)
9.2.2 Multiple Sclerosis (Ms)
Table 98 Injectable Drug Delivery Market Size for Multiple Sclerosis, By Region, 2014–2021 (USD Billion)
9.2.3 Crohn’s Disease
Table 99 Injectable Drug Delivery Market Size for Crohn’s Disease, By Region, 2014–2021 (USD Billion)
9.2.4 Psoriasis
Table 100 Injectable Drug Delivery Market Size for Psoriasis,By Region, 2014–2021 (USD Billion)
9.2.5 Other Autoimmune Diseases
Table 101 Injectable Drug Delivery Market Size for Other Autoimmune Diseases, By Region, 2014–2021 (USD Billion)
9.3 Hormonal Disorders
Table 102 Injectable Drug Delivery Market Size for Hormonal Disorders, By Indication, 2014–2021 (USD Billion)
Table 103 Injectable Drug Delivery Market Size for Hormonal Disorders, By Region, 2014–2021 (USD Billion)
9.3.1 Diabetes
Table 104 Injectable Drug Delivery Market Size for Diabetes,By Region, 2014–2021 (USD Billion)
9.3.2 Anemia
Table 105 Injectable Drug Delivery Market Size for Anemia, By Region, 2014–2021 (USD Billion)
9.3.3 Reproductive Health Disease
Table 106 Injectable Drug Delivery Market Size for Reproductive Health Disease, By Region, 2014–2021 (USD Billion)
9.3.4 Antithrombotic/Thrombolytic Therapy
Table 107 Injectable Drug Delivery Market Size for Antithrombotic/Thrombolytic Therapy, By Region, 2014–2021 (USD Billion)
9.3.5 Osteoporosis
Table 108 Injectable Drug Delivery Market Size for Osteoporosis,By Region, 2014-2021 (USD Billion)
9.3.6 Growth Hormone Deficiency (Ghd)
Table 109 Injectable Drug Delivery Market Size for Growth Hormone Deficiency, By Region, 2014-2021 (USD Billion)
9.4 Orphan Diseases
Table 110 Injectable Drug Delivery Market Size for Orphan Diseases, By Region, 2014-2021 (USD Billion)
9.5 Cancer
Table 111 Injectable Drug Delivery Market Size for Cancer,By Region, 2014-2021 (USD Billion)
9.6 Other Therapeutic Applications
Table 112 Injectable Drug Delivery Market Size for Other Therapeutic Applications, By Indication, 2014-2021 (USD Billion)
Table 113 Injectable Drug Delivery Market Size for Other Therapeutic Applications, By Region, 2014-2021 (USD Billion)
9.6.1 Pain Management
Table 114 Injectable Drug Delivery Market Size for Pain Management, By Region, 2014-2021 (USD Billion)
9.6.2 Allergies
Table 115 Injectable Drug Delivery Market Size for Allergies,By Region, 2014-2021 (USD Billion)
9.6.3 Aesthetic Treatment
Table 116 Injectable Drug Delivery Market Size for Aesthetic Treatments, By Region, 2014-2021 (USD Million)
9.6.4 Hepatitis C
Table 117 Injectable Drug Delivery Market Size for Hepatitis C,By Region, 2014-2021 (USD Billion)
9.6.5 Hemophilia
Table 118 Injectable Drug Delivery Market Size for Hemophilia,By Region, 2014-2021 (USD Million)
10 Injectable Drug Delivery Market, By Usage Pattern (Page No. - 137)
10.1 Introduction
Table 119 Injectable Drug Delivery Market Size, By Usage Pattern, 2014–2021 (USD Billion)
10.2 Curative Care
Table 120 Pipeline Curative Care Drugs (2016-2020)
Table 121 Injectable Drug Delivery Market Size for Curative Care,By Region, 2014–2021 (USD Billion)
10.3 Immunization
Table 122 Injectable Drug Delivery Market Size for Immunization,By Region, 2014–2021 (USD Billion)
10.4 Others
Table 123 Injectable Drug Delivery Market Size for Other Usage Patterns, By Region, 2014–2021 (USD Billion)
11 Injectable Drug Delivery Market, By Site of Administration (Page No. - 142)
11.1 Introduction
Table 124 Injectable Drug Delivery Market Size, By Site of Administration, 2014–2021 (USD Billion)
11.2 Skin (Intradermal and Subcutaneous)
Table 125 Market for Injectable Drug Delivery Through Skin,By Region, 2014–2021 (USD Billion)
11.3 Circulatory/Musculoskeletal System (Intravenous, Intracardiac, Intramuscular, and Intraperitoneal)
Table 126 Market for Injectable Drug Delivery Through Circulatory/Musculoskeletal System, By Region,2014–2021 (USD Billion)
11.4 Organs (Intravitreal and Intra-Articular)
Table 127 Market for Injectable Drug Delivery Through Organs,By Region, 2014–2021 (USD Billion)
11.5 Central Nervous System (Intracerebral and Intrathecal)
Table 128 Market for Injectable Drug Delivery Through Central Nervous System, By Region, 2014–2021 (USD Billion)
12 Injectable Drug Delivery Market, By Distribution Channel (Page No. - 148)
12.1 Introduction
Table 129 Injectable Drug Delivery Market Size, By Distribution Channel, 2014–2021 (USD Billion)
12.2 Hospitals
Table 130 Injectable Drug Delivery Market Size for Hospitals,By Region, 2014–2021 (USD Million)
12.3 Retail Pharmacy Stores
Table 131 Injectable Drug Delivery Market Size for Retail Pharmacy Stores, By Region, 2014–2021 (USD Million)
13 Injectable Drug Delivery Market, By Facility of Use (Page No. - 151)
13.1 Introduction
Table 132 Injectable Drug Delivery Market Size, By Facility of Use, 2014–2021 (USD Billion)
13.2 Hospitals and Clinics
Table 133 Injectable Drug Delivery Market Size for Hospitals and Clinics, By Region, 2014–2021 (USD Billion)
13.3 Home Care Settings
Table 134 Injectable Drug Delivery Market Size for Home Care Settings, By Region, 2014–2021 (USD Billion)
13.4 Other Facilities of Use
Table 135 Injectable Drug Delivery Market Size for Other Facilities of Use, By Region, 2014–2021 (USD Billion)
14 Injectable Drug Delivery Market, By Region (Page No. - 156)
14.1 Introduction
Table 136 Injectable Drug Delivery Market Size, By Region,2014–2021 (USD Billion)
14.2 North America
Table 137 North America: Injectable Drug Delivery Market Size,By Country, 2014-2021 (USD Billion)
Figure 17 North America: Injectable Drug Delivery Market Snapshot
Table 138 North America: Injectable Drug Delivery Market Size,By Type, 2014–2021 (USD Billion)
Table 139 North America: Injectable Drug Delivery Market Size,By Device, 2014-2021 (USD Billion)
Table 140 North America: Injectable Drug Delivery Market Size,By formulation, 2014-2021 (USD Billion)
Table 141 North America: Injectable Drug Delivery Market Size,By Therapeutic Application, 2014-2021 (USD Billion)
Table 142 North America: Injectable Drug Delivery Market Size,By Usage Pattern, 2014-2021 (USD Billion)
Table 143 North America: Injectable Drug Delivery Market Size,By Site of Administration, 2014-2021 (USD Billion)
Table 144 North America: Injectable Drug Delivery Market Size,By Facility of Use, 2014-2021 (USD Billion)
Table 145 North America: Injectable Drug Delivery Market Size,By formulation Packaging, 2014-2021 (USD Billion)
Table 146 North America: Injectable Drug Delivery Market Size,2014-2021 (USD Billion)
14.2.1 U.S.
Table 147 U.S.: Injectable Drug Delivery Market Size, By Type,2014–2021 (USD Billion)
Table 148 U.S.: Injectable Drug Delivery Market Size, By Device,2014–2021 (USD Billion)
Table 149 U.S.: Injectable Drug Delivery Market Size, By Formulation, 2014-2021 (USD Billion)
Table 150 U.S.: Injectable Drug Delivery Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 151 U.S.: Injectable Drug Delivery Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 152 U.S.: Injectable Drug Delivery Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 153 U.S.: Injectable Drug Delivery Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 154 U.S.: Injectable Drug Delivery Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 155 U.S.: Injectable Drug Delivery Market Size, By Distribution Channel, 2014-2021 (USD Billion)
14.2.2 Canada
Table 156 List of Injectables Launched In Canada (2014-2015)
Table 157 Canada: Injectable Drug Delivery Market Size, By Type, 2014-2021 (USD Billion)
Table 158 Canada: Injectable Drug Delivery Market Size, By Device, 2014-2021 (USD Billion)
Table 159 Canada: Injectable Drug Delivery Market Size,By Formulation, 2014-2021 (USD Billion)
Table 160 Canada: Injectable Drug Delivery Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 161 Canada: Injectable Drug Delivery Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 162 Canada: Injectable Drug Delivery Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 163 Canada: Injectable Drug Delivery Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 164 Canada: Injectable Drug Delivery Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 165 Canada: Injectable Drug Delivery Market Size, By Distribution Channel, 2014-2021 (USD Billion)
14.3 Europe
Figure 18 Europe: Injectable Drug Delivery Market Snapshot
Table 166 Europe: Injectable Drug Delivery Market Size, By Country, 2014-2021 (USD Billion)
Table 167 Europe: Injectable Drug Delivery Market Size, By Type,2014–2021 (USD Billion)
Table 168 Europe: Injectable Drug Delivery Market Size, By Device, 2014-2021 (USD Billion)
Table 169 Europe: Injectable Drug Delivery Market Size,By Formulation, 2014-2021 (USD Billion)
Table 170 Europe: Injectable Drug Delivery Market Size,By Therapeutic Application, 2014-2021 (USD Billion)
Table 171 Europe: Injectable Drug Delivery Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 172 Europe: Injectable Drug Delivery Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 173 Europe: Injectable Drug Delivery Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 174 Europe: Injectable Drug Delivery Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 175 Europe: Injectable Drug Delivery Market Size, By Distribution Channel, 2014-2021 (USD Billion)
14.3.1 Germany
Table 176 Germany: Injectable Drug Delivery Market Size, By Type, 2014-2021 (USD Billion)
Table 177 Germany: Injectable Drug Delivery Market Size, By Device, 2014-2021 (USD Billion)
Table 178 Germany: Injectable Drug Delivery Market Size,By Formulation, 2014-2021 (USD Billion)
Table 179 Germany: Injectable Drug Delivery Market Size,By Therapeutic Application, 2014-2021 (USD Billion)
Table 180 Germany: Injectable Drug Delivery Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 181 Germany: Injectable Drug Delivery Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 182 Germany: Injectable Drug Delivery Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 183 Germany: Injectable Drug Delivery Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 184 Germany: Injectable Drug Delivery Market Size, By Distribution Channel, 2014-2021 (USD Billion)
14.3.2 France
Table 185 France: Injectable Drug Delivery Market Size, By Type,2014–2021 (USD Billion)
Table 186 France: Injectable Drug Delivery Market Size, By Device, 2014-2021 (USD Billion)
Table 187 France: Injectable Drug Delivery Market Size,By Formulation, 2014-2021 (USD Billion)
Table 188 France: Injectable Drug Delivery Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 189 France: Injectable Drug Delivery Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 190 France: Injectable Drug Delivery Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 191 France: Injectable Drug Delivery Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 192 France: Injectable Drug Delivery Market Size,By Formulation Packaging, 2014-2021 (USD Billion)
Table 193 France: Injectable Drug Delivery Market Size,By Distribution Channel, 2014-2021 (USD Billion)
14.3.3 U.K.
Table 194 U.K.: Injectable Drug Delivery Market Size, By Type,2014–2021 (USD Billion)
Table 195 U.K.: Injectable Drug Delivery Market Size, By Device,2014–2021 (USD Billion)
Table 196 U.K.: Injectable Drug Delivery Market Size, By Formulation, 2014-2021 (USD Billion)
Table 197 U.K.: Injectable Drug Delivery Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 198 U.K.: Injectable Drug Delivery Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 199 U.K.: Injectable Drug Delivery Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 200 U.K.: Injectable Drug Delivery Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 201 U.K.: Injectable Drug Delivery Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 202 U.K.: Injectable Drug Delivery Market Size, By Distribution Channel, 2014-2021 (USD Billion)
14.3.4 Italy
Table 203 Italy: Injectable Drug Delivery Market Size, By Type,2014–2021 (USD Billion)
Table 204 Italy: Injectable Drug Delivery Market Size, By Device,2014–2021 (USD Billion)
Table 205 Italy: Injectable Drug Delivery Market Size, By Formulation, 2014-2021 (USD Billion)
Table 206 Italy: Injectable Drug Delivery Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 207 Italy: Injectable Drug Delivery Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 208 Italy: Injectable Drug Delivery Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 209 Italy: Injectable Drug Delivery Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 210 Italy: Injectable Drug Delivery Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 211 Italy: Injectable Drug Delivery Market Size, By Distribution Channel, 2014-2021 (USD Billion)
14.3.5 Spain
Table 212 Spain: Injectable Drug Delivery Market Size, By Type,2014–2021 (USD Billion)
Table 213 Spain: Injectable Drug Delivery Market Size, By Device, 2014-2021 (USD Million)
Table 214 Spain: Injectable Drug Delivery Market Size, By Formulation, 2014-2021 (USD Billion)
Table 215 Spain: Injectable Drug Delivery Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 216 Spain: Injectable Drug Delivery Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 217 Spain: Injectable Drug Delivery Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 218 Spain: Injectable Drug Delivery Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 219 Spain: Injectable Drug Delivery Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 220 Spain: Injectable Drug Delivery Market Size, By Distribution Channel, 2014-2021 (USD Billion)
14.3.6 Rest of Europe (Roe)
Table 221 Roe: Injectable Drug Delivery Market Size, By Type,2014–2021 (USD Billion)
Table 222 Roe: Injectable Drug Delivery Market Size, By Device,2014–2021 (USD Billion)
Table 223 Roe: Injectable Drug Delivery Market Size, By Formulation, 2014-2021 (USD Billion)
Table 224 Roe: Injectable Drug Delivery Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 225 Roe: Injectable Drug Delivery Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 226 Roe: Injectable Drug Delivery Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 227 Roe: Injectable Drug Delivery Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 228 Roe: Injectable Drug Delivery Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 229 Roe: Injectable Drug Delivery Market Size, By Distribution Channel, 2014-2021 (USD Billion)
14.4 Asia
Figure 19 Asia: Injectable Drug Delivery Market Snapshot
Table 230 Asia: Injectable Drug Delivery Market Size, By Country, 2014-2021 (USD Billion)
Table 231 Asia: Injectable Drug Delivery Market Size, By Type,2014–2021 (USD Billion)
Table 232 Asia: Injectable Drug Delivery Market Size, By Device,2014–2021 (USD Billion)
Table 233 Asia: Injectable Drug Delivery Market Size, By Formulation, 2014-2021 (USD Billion)
Table 234 Asia: Injectable Drug Delivery Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 235 Asia: Injectable Drug Delivery Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 236 Asia: Injectable Drug Delivery Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 237 Asia: Injectable Drug Delivery Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 238 Asia: Injectable Drug Delivery Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 239 Asia: Injectable Drug Delivery Market Size, By Distribution Channel, 2014-2021 (USD Billion)
14.4.1 China
Table 240 China: Injectable Drug Delivery Market Size, By Type,2014–2021 (USD Billion)
Table 241 China: Injectable Drug Delivery Market Size, By Device, 2014-2021 (USD Billion)
Table 242 China: Injectable Drug Delivery Market Size,By Formulation, 2014-2021 (USD Billion)
Table 243 China: Injectable Drug Delivery Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 244 China: Injectable Drug Delivery Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 245 China: Injectable Drug Delivery Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 246 China: Injectable Drug Delivery Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 247 China: Injectable Drug Delivery Market Size,By Formulation Packaging, 2014-2021 (USD Billion)
Table 248 China: Injectable Drug Delivery Market Size,By Distribution Channel, 2014-2021 (USD Billion)
14.4.2 Japan
Table 249 Japan: Injectable Drug Delivery Market Size, By Type,2014–2021 (USD Billion)
Table 250 Japan: Injectable Drug Delivery Market Size, By Device, 2014-2021 (USD Billion)
Table 251 Japan: Injectable Drug Delivery Market Size,By Formulation, 2014-2021 (USD Billion)
Table 252 Japan: Injectable Drug Delivery Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 253 Japan: Injectable Drug Delivery Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 254 Japan: Injectable Drug Delivery Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 255 Japan: Injectable Drug Delivery Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 256 Japan: Injectable Drug Delivery Market Size,By Formulation Packaging, 2014-2021 (USD Billion)
Table 257 Japan: Injectable Drug Delivery Market Size,By Distribution Channel, 2014-2021 (USD Billion)
14.4.3 India
Table 258 India: Injectable Drug Delivery Market Size, By Type,2014–2021 (USD Billion)
Table 259 India: Injectable Drug Delivery Market Size, By Device,2014–2021 (USD Billion)
Table 260 India: Injectable Drug Delivery Market Size,By Formulation, 2014-2021 (USD Billion)
Table 261 India: Injectable Drug Delivery Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 262 India: Injectable Drug Delivery Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 263 India: Injectable Drug Delivery Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 264 India: Injectable Drug Delivery Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 265 India: Injectable Drug Delivery Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 266 India: Injectable Drug Delivery Market Size, By Distribution Channel, 2014-2021 (USD Billion)
14.4.4 Rest of Asia
Table 267 Roa: Injectable Drug Delivery Market Size, By Type,2014–2021 (USD Billion)
Table 268 Roa: Injectable Drug Delivery Market Size, By Device,2014–2021 (USD Billion)
Table 269 Roa: Injectable Drug Delivery Market Size, By Formulation, 2014-2021 (USD Billion)
Table 270 Roa: Injectable Drug Delivery Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 271 Roa: Injectable Drug Delivery Market Size, By Usage Pattern, 2014-2021 (USD Million)
Table 272 Roa: Injectable Drug Delivery Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 273 Roa: Injectable Drug Delivery Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 274 Roa: Injectable Drug Delivery Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 275 Roa: Injectable Drug Delivery Market Size, By Distribution Channel, 2014-2021 (USD Billion)
14.5 Rest of The World (Row)
Figure 20 Rest of The World: Injectable Drug Delivery Market Snapshot
Table 276 Row: Injectable Drug Delivery Market Size, By Type,2014–2021 (USD Billion)
Table 277 Row: Injectable Drug Delivery Market Size, By Device,2014–2021 (USD Billion)
Table 278 Row: Injectable Drug Delivery Market Size, By Formulation, 2014-2021 (USD Billion)
Table 279 Row: Injectable Drug Delivery Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 280 Row: Injectable Drug Delivery Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 281 Row: Injectable Drug Delivery Market Size, By Site of Administration, 2014–2021 (USD Billion)
Table 282 Row: Injectable Drug Delivery Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 283 Row: Injectable Drug Delivery Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 284 Row: Injectable Drug Delivery Market Size, By Distribution Channel, 2014-2021 (USD Billion)
15 Competitive Landscape (Page No. - 227)
15.1 Overview
Figure 21 Key Players Adopted Inorganic Growth Strategies Between 2013 and 2016
Figure 22 Injectable Drug Delivery Market Evolution Framework, 2013–2016
15.2 Market Share Analysis
Figure 23 Global Injectable Drug Delivery Market Share Analysis, 2015
15.3 Competitive Situation and Trends
Figure 24 Battle for Market Share: Partnerships, Agreements, and Collaborations are The Key Strategies Adopted By Market Players
15.3.1 Partnerships, Agreements, and Collaborations
Table 285 Partnerships, Agreements, and Collaborations(2013–2016) 230
15.3.2 Product Launches, Approvals, and Enhancements
Table 286 Product Launches, Approvals, and Enhancements(2013–2016) 230
15.3.1 Expansions
Table 287 Expansions (2013–2016)
15.3.2 Acquisitions
Table 288 Acquisitions (2013–2016)
16 Company Profiles (Page No. - 233)
(Business Overview, Products offered, Recent Developments, and Mnm View)*
16.1 Introduction
Figure 25 Geographic Benchmarking of Top 5 Players
16.2 Baxter International, Inc.
Figure 26 Baxter International, Inc.: Company Snapshot (2015)
16.3 Becton, Dickinson and Company
Figure 27 Becton, Dickinson and Company: Company Snapshot (2015)
16.4 Gerresheimer Ag
Figure 28 Gerresheimer Ag: Company Snapshot (2015)
16.5 Pfizer, Inc.
Figure 29 Pfizer, Inc.: Company Snapshot (2015)
16.6 Schott Ag
Figure 30 Schott Ag: Company Snapshot (2015)
16.7 Eli Lilly and Company
Figure 31 Eli Lilly and Company: Company Snapshot (2015)
16.8 Sandoz (A Division of Novartis Ag)
Figure 32 Sandoz: Company Snapshot (2015)
16.9 Terumo Corporation
Figure 33 Terumo Corporation: Company Snapshot (2015)
16.1 Teva Pharmaceutical Industries Ltd.
Figure 34 Teva Pharmaceutical Industries Ltd.: Company Snapshot (2015)
17 Appendix (Page No. - 257)
17.1 Insights From Industry Experts
17.2 Discussion Guide
17.3 Other Recent Developments
17.4 Available Customizations
17.5 Knowledge Store: Marketsandmarkets’ Subscription Portal
17.6 Rt: Real-Time Market Intelligence
17.7 Related Reports
17.8 Author Details
Generating Response ...
Growth opportunities and latent adjacency in Injectable Drug Delivery Market